| [1] |
Integrated Chinese and Western Medicine Ovarian Cancer Specialty Committee of China Anti-Cancer Association.
China expert consensus on diagnosis and treatment of low-grade serous ovarian cancer (2024 edition)
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 11-20.
|
| [2] |
LIANG Shuang, XIE Yuanliang, FENG Chao, LU Qinchen, TAO Yuting, LV Yuqi, LI Tianyu, WANG Qiuyan, TANG Shaomei.
Analyzing the impact of lncRNA MBNL1-AS1 on the molecular characteristics of Basal subtype muscle-invasive bladder cancer based on omics technologies
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 21-29.
|
| [3] |
LI Lei, LIU Xiaodan, ZHOU Kaixiang, HE Linjie, ZHANG Jian, CHEN Qiang, MENG Han, FENG Huan, ZHANG Wenming, LU Jun, ZHOU Feng, CUI Hongzun, NIU Wancheng, ZHANG Zhaohui.
Effects of ischemia postconditioning on mitochondrial function in rats and its protective mechanisms in hepatic ischemia-reperfusion injury
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 48-54.
|
| [4] |
YANG Jun, KANG Wei, ZHONG Wuning, ZHAO Xin.
Predictive value of radiomics model based on cone-beam breast CT images for pathological complete response of neoadjuvant therapy in breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 103-108.
|
| [5] |
ZHANG Yuanfen, LONG Ying, YAO Desheng.
Relationship between perineural invasion,clinical pathological characteristics of cervical cancer and its effects on prognosis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 109-114.
|
| [6] |
XUAN Wenzhen, GONG Jianmin, LI Na.
Incidence,mortality,and disease burden of cervical cancer in China,1990—2021: trends over the past 30 years and future prediction
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 694-700.
|
| [7] |
LU Tingting, SHI Lijun, LIU Yingzhao, LIANG Huiting, WANG Qi.
Down⁃regulation of α2⁃macroglobulin expression activates TGF⁃β/SMADs signaling pathway to induce cisplatin resistance in ovarian cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 707-714.
|
| [8] |
ZHANG Xiaomeng, WANG Yue, WAN Qiaoqin.
Summary of evidence for the management of drug-related symptoms during endocrine therapy in breast cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 615-621.
|
| [9] |
ZHANG Yening, PANG Ying, HE Yi, TANG Lili.
Status quo and reflections on psychological pain and psychotherapy in patients with advanced breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 622-628.
|
| [10] |
Gynecological Oncology Group, the Invasive and Noninvasive Medical Committee of Chinese Medical Doctor Association, Reproductive Tract Disease Diagnosis and Treatment Branch of the China Healthy Birth Science Association, Oncofertility Branch of the China Healthy Birth Science Association.
Chinese consensus experts on diagnosis and treatment of uterine carcinosarcoma (2024 edition)
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 385-391.
|
| [11] |
LI Tingting, LIU Yan .
Comparison of the separation and purification methods of small extracellular vesicles in mesenchymal stem cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 424-432.
|
| [12] |
SU Lili, LAN Zhenyu, LIN Huizhe, YAN Fangna, CHEN Weilian, LIN Wei.
Effects of sarcopenia on prognosis of prostate cancer treatment: a Meta-analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 487-493.
|
| [13] |
LU Yubo, FANG Yanle, WEI Jianxin, GAO Yuguang, LANG Xing, LI Jingtao, MA Xinsheng.
Effects of artesunate on proliferation,apoptosis and autophagy of nephroblastoma cells by regulating AMPK/mTOR/ULK1 signaling pathway
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 295-301.
|
| [14] |
XIE Changquan, HE Fengyi, LU Guodong, LI Qiuyun.
Andrographolide combined with doxorubicin induces cell death in breast cancer cell via ROS-dependent DNA damage
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 302-307.
|
| [15] |
SUN Xiaoxia, WANG Yuping, SI Meili, ZHU Jing, ZHONG Mei.
Trends of incidence and mortality and the age-period-cohort of cervical cancer in China,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 317-320.
|
